Depression remission · women of any age, with PND up to 12 months
It is very uncertain whether antidepressants changes depression remission (acute phase, 5 ≤ 12 weeks) compared with any other pharmacological intervention (very low certainty).
2 findings from 1 review
RR 0.98 [0.68, 1.41]
Studies not reported
Very low
no estimate extracted
Studies not reported
Low
Depression response (early phase, < 5 weeks) · women of any age, with PND up to 12 months
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Depression severity (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Depression response (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months
It is very uncertain whether antidepressants changes depression response (acute phase, 5 ≤ 12 weeks) compared with any complementary medicine (very low certainty).
1 finding from 1 review
RR 1.23 [0.71, 2.12]
Studies not reported
Very low
Depression remission · women of any age, with PND up to 12 months
It is very uncertain whether antidepressants changes depression remission (acute phase, 5 ≤ 12 weeks) compared with any complementary medicine (very low certainty).
1 finding from 1 review
RR 1.17 [0.44, 3.09]
Studies not reported
Very low
Depression severity · women of any age, with PND up to 12 months
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression severity (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months
2 findings from 1 review
no estimate extracted
Studies not reported
Low
no estimate extracted
Studies not reported
Low
Depression response or remission (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression at 12 weeks · people with inflammatory bowel disease
1 finding from 1 review
Depression at 12 months · people with inflammatory bowel disease
1 finding from 1 review
Depressive symptoms · treatment of disordered and problem gambling
1 finding from 1 review
Depressive symptoms · treatment of disordered and problem gambling
1 finding from 1 review
Depressive symptoms · treatment of disordered and problem gambling
1 finding from 1 review
Depression (post‐treatment score on self report and clinician‐rated scales) Different self report and clinician‐rated scales (HDRS, BDI) · somatoform disorders in adults
1 finding from 1 review
Depression Measured after 52 weeks HADS depression score, 0‐21 points Low score means fewer symptoms · men and women aged over 18 years with chronic fatigue syndrome
1 finding from 1 review
Depression Long term · men and women aged over 18 years with chronic fatigue syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical global impression (response rate) ‐ desipramine · Children and adolescents with ADHD
Tricyclic antidepressants (TCAs) may leads to higher clinical global impression (response rate) ‐ desipramine compared with placebo (low certainty).
1 finding from 1 review
Efficacy as a continuous outcome · adults with cancer and depression
1 finding from 1 review
Efficacy as a dichotomous outcome · adults with cancer and depression
It is very uncertain whether antidepressants changes efficacy as a dichotomous outcome compared with placebo (very low certainty).
1 finding from 1 review
Acceptability ‐ total dropouts · adults with cancer and depression
It is very uncertain whether antidepressants changes dropouts due to any cause (acceptability) compared with placebo (very low certainty).
1 finding from 1 review